Jill M. Quigley - 16 Jun 2023 Form 4 Insider Report for Chemomab Therapeutics Ltd. (CMMB)

Role
Director
Signature
/s/ David S. Glatt, Attorney-in-Fact for Jill M. Quigley
Issuer symbol
CMMB
Transactions as of
16 Jun 2023
Net transactions value
$0
Form type
4
Filing time
20 Jun 2023, 06:03:03 UTC
Previous filing
14 Jun 2023
Next filing
17 Nov 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CMMB Option to Purchase American Depositary Shares Award $0 +6,857 +50% $0.000000 20,497 16 Jun 2023 American Depositary Shares 6,857 $1.71 Direct F1, F2
transaction CMMB Option to Purchase American Depositary Shares Award $0 +13,640 $0.000000 13,640 16 Jun 2022 American Depositary Shares 13,640 $3.25 Direct F1, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.
F2 These options shall vest and become exercisable in full at the end of the 12 month period commencing on June 16, 2023 subject to the Reporting Person's continued service.
F3 No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this form 4 for informational purposes only.
F4 These options vest and become exercisable in equal monthly installments over a 36 month period commencing on June 16, 2022, subject to the Reporting Person's continued service.